21.40
+0.49(+2.34%)
Currency In CNY
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
3197
First IPO Date
June 30, 2015
| Name | Title | Pay | Year Born |
| Cai Mei Peng | Accounting Supervisor | 0 | N/A |
| Yaping Zhao | Deputy General Manager & Non-Independent Director | 0 | 1977 |
| Zhongxiong Peng | GM & Director | 0 | 1974 |
| Fang Xia Yu | Chief Financial Officer & Deputy GM | 0 | 1976 |
| Hong Hu | Board Secretary | 0 | 1983 |
| Ke Ren Kang | Deputy General Manager | 0 | 1976 |
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.